$0.648
+0 (+0%)
At Close: Jan 12, 2024
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
02:45pm, Monday, 21'st Mar 2022 Zacks Investment Research
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most. However, reimbur
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
12:03pm, Monday, 21'st Mar 2022
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most.
Rite Aid to Release Fourth Quarter Results on April 14
08:30am, Thursday, 17'th Mar 2022
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2022 Fourth Quarter, which ended February 26, 2022, on Thursday, Apri
Rite Aid stock gains after speculation of activist after management changes (NYSE:RAD)
02:57pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Rite Aid (RAD) rose 2.3% after some speculation that the drugstore chain could be a target of an activist after a management realignment was announced Tuesday.Rite Aid disclosed that…
Rite Aid realigns management team
01:34pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Rite Aid (RAD) has realigned its management team to streamline its operations.The move will see the elimination of the Rite Aid Chief Operating Officer ((COO)) position and consolidation…
Rite Aid eliminates COO position as part of management realignment
01:12pm, Tuesday, 08'th Mar 2022 MarketWatch
Shares of Rite Aid Corp. were indicated up nearly 1% in premarket trading Tuesday, after the drug store chain announced a realignment of its management team that includes the elimination of the chief operating officer (COO) position and consolidation of leadership of its pharmacy business. As part of the realignment, COO Jim Peters and Chief Pharmacy Officer Jocelyn Konrad have left the company, after both were in their roles since October 2019. Karen Staniforth, senior vice president of clinical pharmacy services, was named chief pharmacy officer, while Chief Retail Officer Andre Persaud will take over field operations for pharmacy and will oversee front-end operations. "The changes we announced today are part of our ongoing efforts to reduce costs and remove layers," said Chief Executive Heyward Donigan. Rite Aid''s stock has dropped 28.1% over the past three months through Monday, while the S&P 500 has lost 10.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.
Rite Aid Shakes Up Management, Eliminates COO Position
10:03am, Tuesday, 08'th Mar 2022
Rite Aid eliminated its chief operating officer position and consolidated pharmacy roles to “streamline operations.”
Rite Aid eliminates COO position as part of management realignment
08:12am, Tuesday, 08'th Mar 2022
Shares of Rite Aid Corp. RAD, -1.42% were indicated up nearly 1% in premarket trading Tuesday, after the drug store chain announced a realignment of its management team that includes the elimination o
Here's Why You Should Invest in Bio-Rad (BIO) Stock Now
09:45am, Monday, 07'th Mar 2022
Investors are optimistic about Bio-Rad (BIO) on solid recovery in most of its key global markets as well as an uptick in demand for COVID-related products.
Rite Aid Corporation – Consensus Indicates Potential 52.2% Upside
04:05pm, Saturday, 05'th Mar 2022 DirectorsTalk
Rite Aid Corporation with ticker code (RAD) now have 2 analysts covering the stock. The analyst consensus points to a rating of ''Underperform''. The target price ranges between 16 and 12 calculating the mean target price we have 14. Given that the stocks previous close was at 9.2 this would indicate that there is a potential upside of 52.2%. There is a 50 day moving average of 11.53 while the 200 day moving average is 14.6. The company has a market cap of $512m. You can visit the company''s website by visiting: https://www.riteaid.com [stock_market_widget type="chart" template="basic" color="green" assets=RAD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $779m based on the market concensus. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, pet care, and other every day and convenience products, as well as brand and generic prescription drugs.
36 Stocks To Watch After Biden's First State of The Union Address
07:48pm, Wednesday, 02'nd Mar 2022 Benzinga
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped pass along with more fu
Rite Aid Donates $900K To Support Healthy Food Programs In Detroit
05:44pm, Monday, 28'th Feb 2022 CBS Detroit
Two programs that provide access to food in Detroit neighborhoods will share $900,000 from Rite Aid Healthy Futures.
Is the Pharmacy Dying?
02:42pm, Wednesday, 23'rd Feb 2022 The Motley Fool
Pharmacy chains may be shuttering locations, but that's not necessarily a reason to panic.
Is the Pharmacy Dying?
09:42am, Wednesday, 23'rd Feb 2022
Pharmacy chains may be shuttering locations, but that's not necessarily a reason to panic.
Rite Aid Corporation Consensus Indicates Potential 40.0% Upside
11:01am, Sunday, 20'th Feb 2022 DirectorsTalk
Rite Aid Corporation with ticker code (RAD) now have 2 analysts in total covering the stock. The consensus rating is ''Underperform''. The target price ranges between 16 and 12 calculating the mean target price we have 14. Now with the previous closing price of 10 this would indicate that there is a potential upside of 40.0%. The day 50 moving average is 12.06 while the 200 day moving average is 14.97. The company has a market cap of $556m. You can visit the company''s website by visiting: https://www.riteaid.com [stock_market_widget type="chart" template="basic" color="green" assets=RAD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $779m based on the market concensus. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, pet care, and other every day and convenience products, as well as brand and generic prescription drugs.
Sign In
Buy RAD